Skip to main content

CAR T Cell Therapy Poised to Transform Autoimmune Disease Treatment

January 22, 2026
A groundbreaking clinical trial featured in Nature Medicine’s “Eleven Clinical Trials That Will Shape Medicine in 2026” is redefining the future of autoimmune disease treatment. The study, led by Dr. James Howard and Cartesian Therapeutics, explores the use of mRNA-based CAR T cell therapy for myasthenia gravis, a chronic autoimmune...

Dr. Rebecca Traub Receives Award to Advance CMT Studies

January 9, 2026
We are excited to announce that Dr. Rebecca Traub, Principal Investigator at The University of North Carolina, has been selected to receive an award from the Charcot-Marie-Tooth Association (CMTA) to support research within the Inherited Neuropathy Consortium (INC). The INC is a collaborative network of academic medical centers, patient advocacy...

Chelsea Simmons Named Co-Chair of NEALS APP Committee

January 8, 2026
UNC Neurology is proud to announce that Chelsea Simmons, Advanced Practice Provider (APP), has been selected to serve as Co-Chair of the NEALS APP Committee. This appointment recognizes Chelsea’s dedication to advancing ALS care and research. NEALS (Network for Excellence in ALS) is the leading research collaboration focused on exploring...

UNC ALS Clinic Designated as ALS Association Certified Treatment Center of Excellence

November 4, 2025
We are proud to announce that the University of North Carolina ALS Clinic has officially been designated as an ALS Association Certified Treatment Center of Excellence! This recognition reflects the clinic’s commitment to providing outstanding, compassionate, and multidisciplinary care to individuals living with ALS and their families. The designation was...

Neurological Services Expand ALS care to Patients Living in Western North Carolina

October 30, 2025
A new clinic will bring ALS care to support the unique needs of individuals living in rural North Carolina. UNC Health Pardee has expanded its neurological services with the opening of a dedicated Amyotrophic Lateral Sclerosis (ALS) Clinic, the first multidisciplinary clinic of its kind in the region.

Promotion – Dr. Rebecca Traub

September 24, 2025
UNC Department of Neurology is please to announce the promotion of Dr. Rebecca Traub from Clinical Associate Professor to Clinical Professor based on excellence in clinical activity. Dr. Traub completed her Bachelor of Arts degree from Brown University in 2002. Following her BA, Dr. Traub earned a Doctor of Medicine...

Dr. James F. Howard Jr. Leads Groundbreaking Study in Myasthenia Gravis Treatment

August 26, 2025
Dr. James F. Howard Jr., Professor of Neurology at the University of North Carolina at Chapel Hill School of Medicine, has played a pivotal role as Principal Investigator in the ADAPT SERON study—marking a major advancement in the treatment of generalized myasthenia gravis (gMG). The study, conducted by global immunology...

UNC Neurology Celebrates Opening of New Pediatric Muscular Dystrophy Association (MDA) Clinic

May 14, 2025
Making specialized care more accessible for children with neuromuscular disorders The UNC Department of Neurology is thrilled to announce the grand opening of the new UNC Pediatric Muscular Dystrophy Association (MDA) Clinic. This dedicated clinic, which officially began welcoming patients on May 9th, 2025, is conveniently located within the pediatric...

Dr. Vinay Chaudhry Honored with AINA’s Prestigious Kapil Sethi Teaching Award

April 8, 2025
The Association of Indian Neurologists in America (AINA) has recognized Dr. Vinay Chaudhry for his exceptional contributions to neurology education by selecting him as this year’s recipient of the Kapil Sethi, MD, FRCP Teaching Award. In announcing the award, the AINA Awards Selection Committee expressed deep admiration for Dr. Chaudhry’s...

UNC Undergraduates Delve into Cutting-Edge Neurological Disease Treatments

April 1, 2025
A unique course at the University of North Carolina at Chapel Hill is providing undergraduate students with an in-depth exploration of the latest advancements in neurological disease research and treatment. Titled “Next-Generation Treatments for Neurological Diseases,” the course offers a rigorous examination of five critical conditions: Alzheimer’s, Parkinson’s, Glioblastoma, ALS,...